Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-26-456632·Nant Capital, LLC
Schedule 13D ownership disclosure
PDS BIOTECHNOLOGY CORP
Common Stock, par value $0.00033 per share · CUSIP: 70465T107
Event date: 2026-11-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nant Capital, LLCReported CIK 0001675758
Shares: 22,856,453.00 · Class: 19.9%
- Patrick Soon-Shiong
Shares: 22,856,453.00 · Class: 19.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-456632
- Form type
- SCHEDULE 13D/A
- Filer
- Nant Capital, LLC
- CIK
- CIK 1675758
- Filed
- Nov 12, 2026
- Reporting period
- Nov 09, 2026
- Description
- Schedule 13D beneficial ownership